Drugs / Autologous EPCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00936819 | Jul 2013 → Mar 2020 overdue | myocardial infarction | Ottawa Hospital Research Institute | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous EPCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00936819 ↗ |
| Route | Other | “Single dose of 20 million cells in 8 mls given by investigator via intracoronary injection into stent of infarct-related artery” NCT00936819 ↗ |